Dyspepsia Market- Global Industry Analysis and forecast 2023 – 2029


Dyspepsia Market size was valued at US$ 1.37 Bn. in 2022 and the total revenue is expected to grow at 4.01% from 2023 to 2029, reaching nearly US$ 1.80 Bn.

Dyspepsia Market Definition

Dyspepsia is also called as stomachache is gastroenterology disorders characterized by persistent or recurrent pain. It is usually a sign of an underlying condition like GERD (gastroesophageal reflux disease), gallbladder and ulcers disease. The dyspepsia patients may experience a burning sensation in the stomach part, severe stomach pain, vomiting, and nausea.Dyspepsia MarketTo know about the Research Methodology:- Request Free Sample Report

The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.

Dyspepsia Market Dynamics

Dyspepsia is a very general symptom, accounting for amid 1.2% and 4% of all discussions in primary care in the United Kingdom. As per the National Institute of Diabetes & Digestive and Kidney Diseases article, it is projected 1 in every 4 people in the U.S. diagnosed with dyspepsia yearly. This rising incidence of dyspepsia globally, irregular intake habits and launch of novel products are the major factors that reinforce the dyspepsia market position. Moreover, in 2018, the American Cancer Society estimated nearly 26,240 new cases of stomach cancer to be analyzed. On the other hand, high costs related to diagnostic tests and cut-throat competition between market companies are some of the factors that are expected to restrict the dyspepsia market growth over 2023-2029. Likewise, the report contains a detailed study of factors that will drive and restrain the growth of the dyspepsia market globally.

Dyspepsia Market Regional Analysis

The report offers a brief analysis of the major regions in the dyspepsia market, namely, APAC, Europe, North America, South America, and the MEA. North America dyspepsia market was valued US$ xx.15 Mn. in 2022 and is expected to reach a value of US$ xx.67 Mn. by 2029, with a CAGR of xx.36% during 2023-2029. This is credited to favourable reimbursement, technological advancements. Consistent with the Centers for Disease Control and Prevention, nearly 3 million people suffered from ulcerative colitis in 2015. It causes infection of the digestive area which might lead to dyspepsia.

Dyspepsia Market Segment Analysis

By End-User, the segment is divided into hospitals and clinics, ambulatory surgical centres, pharmacies, diagnostic centres, and others. Among these, the hospitals and clinics segment held the largest market share of xx% in 2022 and is projected to grow at the highest CAGR of xx.23% to reach US$ xx Mn by 2029 because of the growing prevalence of digestive diseases. The MMR report covers the segments in the dyspepsia market such as diagnosis, treatment, and end-user.

The MMR report also focuses on the major leading industry players globally of dyspepsia market providing information like company profiles, production, and revenue. In 2018, Eisai company has launched Cidine i.e. cinitapride hydrogen tartrate, a stomach prokinetic agent in China for the treatment of mild to moderate functional dyspepsia. The launch is set to change the treatment scenario for dyspepsia suffering patients.

The objective of the report is to present a comprehensive analysis of the Global Dyspepsia Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Dyspepsia Market dynamics, structure by analyzing the market segments and projects the Global Dyspepsia Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Dyspepsia Market make the report investor’s guide.

Global Dyspepsia Market Scope: Inquire before buying






Global Dyspepsia Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2018 to 2022
Market Size in 2022:
US $ 1.37 Bn.




Forecast Period 2023 to 2029 CAGR:
4.01%
Market Size in 2029:
US $ 1.80 Bn.




 Segments Covered:
by Diagnosis
Blood Tests
Breath Tests
Stool Tests
Endoscopy
X-ray
CT scan
Others




by Treatment
Antacids
Antibiotics
H2 Blockers
Proton Pump Inhibitors (PPIs)
Prokinetics
Psychological Therapies
Others




by End User
Hospitals and clinics
Ambulatory surgical centers
Pharmacies
Diagnostic centers
Others






Dyspepsia Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Dyspepsia Market, Key Players are

1. AstraZeneca
2. GlaxoSmithKline
3. Takeda Pharmaceutical
4. Johnson & Johnson
5. Jiangsu Aosaikang Pharma
6. Eisai Co., Ltd.
7. Abbott Laboratories
8. Salix Pharmaceuticals
9. Bayer AG
10. Boehringer Ingelheim GmbH
11. Sanofi
12. Allergan Plc
13. Cadila Pharmaceuticals
14. Pfizer
15. Biogen
16. Astellas Pharma Inc.
17. ZERIA Pharmaceutical Co., Ltd
18. DONG - A ST
19. Beactica AB
20. Xian Janssen Pharmaceutical Ltd
21. Novartis AG
22. YUHAN
23. Abide Therapeutics, Inc.

Frequently Asked questions

1. What is the market size of the Global Dyspepsia Market in 2022?
Ans. The market size Global Dyspepsia Market in 2022 was US$ 1.37 Billion.

2. What are the different segments of the Global Dyspepsia Market ?
Ans. The Global Dyspepsia Market is divided into Diagnosis, Treatment and End-User.

3. What is the study period of this market?
Ans. The Global Dyspepsia Market will be studied from 2022 to 2029.

4. Which region is expected to hold the highest Global Dyspepsia Market share?
Ans. The Asia Pacific dominates the market share in the market.

5. What is the Forecast Period of Global Market ?
Ans. The Forecast Period of the market is 2023-2029 in the market. 




Global Dyspepsia Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: Global Dyspepsia Market Size, by Market Value (US$ Bn)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies

5. Supply Side and Demand Side Indicators

6. Global Dyspepsia Market Analysis and Forecast
6.1. Dyspepsia Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Dyspepsia Market Analysis and Forecast, By End-User
7.1. Introduction and Definition
7.2. Key Findings
7.3. Dyspepsia Market Value Share Analysis, By End-User
7.4. Dyspepsia Market Size (US$ Bn) Forecast, By End-User
7.5. Dyspepsia Market Analysis, By End-User
7.6. Dyspepsia Market Attractiveness Analysis, By End-User

8. Global Dyspepsia Market Analysis and Forecast, By Treatment
8.1. Introduction and Definition
8.2. Key Findings
8.3. Dyspepsia Market Value Share Analysis, By Treatment
8.4. Dyspepsia Market Size (US$ Bn) Forecast, By Treatment
8.5. Dyspepsia Market Analysis, By Treatment
8.6. Dyspepsia Market Attractiveness Analysis, By Treatment

9. Global Dyspepsia Market Analysis and Forecast, By Diagnosis
9.1. Introduction and Definition
9.2. Key Findings
9.3. Dyspepsia Market Value Share Analysis, By Diagnosis
9.4. Dyspepsia Market Size (US$ Bn) Forecast, By Diagnosis
9.5. Dyspepsia Market Analysis, By Diagnosis
9.6. Dyspepsia Market Attractiveness Analysis, By Diagnosis

10. Global Dyspepsia Market Analysis, by Region
10.1. Dyspepsia Market Value Share Analysis, by Region
10.2. Dyspepsia Market Size (US$ Bn) Forecast, by Region
10.3. Dyspepsia Market Attractiveness Analysis, by Region

11. North America Dyspepsia Market Analysis
11.1. Key Findings
11.2. North America Dyspepsia Market Overview
11.3. North America Dyspepsia Market Value Share Analysis, By End-User
11.4. North America Dyspepsia Market Forecast, By End-User
11.4.1. Hospitals and clinics
11.4.2. Ambulatory surgical centers
11.4.3. Pharmacies
11.4.4. Diagnostic centers
11.4.5. Others
11.5. North America Dyspepsia Market Value Share Analysis, By Treatment
11.6. North America Dyspepsia Market Forecast, By Treatment
11.6.1. Antacids
11.6.2. Antibiotics
11.6.3. H2 Blockers
11.6.4. Proton Pump Inhibitors (PPIs)
11.6.5. Prokinetics
11.6.6. Psychological Therapies
11.6.7. Others
11.7. North America Dyspepsia Market Value Share Analysis, By Diagnosis
11.8. North America Dyspepsia Market Forecast, By Diagnosis
11.8.1. Blood Tests
11.8.2. Breath Tests
11.8.3. Stool Tests
11.8.4. Endoscopy
11.8.5. X-ray
11.8.6. CT scan
11.8.7. Others
11.9. North America Dyspepsia Market Value Share Analysis, by Country
11.10. North America Dyspepsia Market Forecast, by Country
11.10.1. U.S.
11.10.2. Canada
11.11. North America Dyspepsia Market Analysis, by Country
11.12. U.S. Dyspepsia Market Forecast, By End-User
11.12.1. Hospitals and clinics
11.12.2. Ambulatory surgical centers
11.12.3. Pharmacies
11.12.4. Diagnostic centers
11.12.5. Others
11.13. U.S. Dyspepsia Market Forecast, By Treatment
11.13.1. Antacids
11.13.2. Antibiotics
11.13.3. H2 Blockers
11.13.4. Proton Pump Inhibitors (PPIs)
11.13.5. Prokinetics
11.13.6. Psychological Therapies
11.13.7. Others
11.14. U.S. Dyspepsia Market Forecast, By Diagnosis
11.14.1. Blood Tests
11.14.2. Breath Tests
11.14.3. Stool Tests
11.14.4. Endoscopy
11.14.5. X-ray
11.14.6. CT scan
11.14.7. Others
11.15. Canada Dyspepsia Market Forecast, By End-User
11.15.1. Hospitals and clinics
11.15.2. Ambulatory surgical centers
11.15.3. Pharmacies
11.15.4. Diagnostic centers
11.15.5. Others
11.16. Canada Dyspepsia Market Forecast, By Treatment
11.16.1. Antacids
11.16.2. Antibiotics
11.16.3. H2 Blockers
11.16.4. Proton Pump Inhibitors (PPIs)
11.16.5. Prokinetics
11.16.6. Psychological Therapies
11.16.7. Others
11.17. Canada Dyspepsia Market Forecast, By Diagnosis
11.17.1. Blood Tests
11.17.2. Breath Tests
11.17.3. Stool Tests
11.17.4. Endoscopy
11.17.5. X-ray
11.17.6. CT scan
11.17.7. Others
11.18. North America Dyspepsia Market Attractiveness Analysis
11.18.1. By End-User
11.18.2. By Treatment
11.18.3. By Diagnosis
11.19. PEST Analysis
11.20. Key Trends
11.21. Key Developments

12. Europe Dyspepsia Market Analysis
12.1. Key Findings
12.2. Europe Dyspepsia Market Overview
12.3. Europe Dyspepsia Market Value Share Analysis, By End-User
12.4. Europe Dyspepsia Market Forecast, By End-User
12.4.1. Hospitals and clinics
12.4.2. Ambulatory surgical centers
12.4.3. Pharmacies
12.4.4. Diagnostic centers
12.4.5. Others
12.5. Europe Dyspepsia Market Value Share Analysis, By Treatment
12.6. Europe Dyspepsia Market Forecast, By Treatment
12.6.1. Antacids
12.6.2. Antibiotics
12.6.3. H2 Blockers
12.6.4. Proton Pump Inhibitors (PPIs)
12.6.5. Prokinetics
12.6.6. Psychological Therapies
12.6.7. Others
12.7. Europe Dyspepsia Market Value Share Analysis, By Diagnosis
12.8. Europe Dyspepsia Market Forecast, By Diagnosis
12.8.1. Blood Tests
12.8.2. Breath Tests
12.8.3. Stool Tests
12.8.4. Endoscopy
12.8.5. X-ray
12.8.6. CT scan
12.8.7. Others
12.9. Europe Dyspepsia Market Value Share Analysis, by Country
12.10. Europe Dyspepsia Market Forecast, by Country
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Europe Dyspepsia Market Analysis, by Country
12.12. Germany Dyspepsia Market Forecast, By End-User
12.12.1. Hospitals and clinics
12.12.2. Ambulatory surgical centers
12.12.3. Pharmacies
12.12.4. Diagnostic centers
12.12.5. Others
12.13. Germany Dyspepsia Market Forecast, By Treatment
12.13.1. Antacids
12.13.2. Antibiotics
12.13.3. H2 Blockers
12.13.4. Proton Pump Inhibitors (PPIs)
12.13.5. Prokinetics
12.13.6. Psychological Therapies
12.13.7. Others
12.14. Germany Dyspepsia Market Forecast, By Diagnosis
12.14.1. Blood Tests
12.14.2. Breath Tests
12.14.3. Stool Tests
12.14.4. Endoscopy
12.14.5. X-ray
12.14.6. CT scan
12.14.7. Others
12.15. U.K. Dyspepsia Market Forecast, By End-User
12.15.1. Hospitals and clinics
12.15.2. Ambulatory surgical centers
12.15.3. Pharmacies
12.15.4. Diagnostic centers
12.15.5. Others
12.16. U.K. Dyspepsia Market Forecast, By Treatment
12.16.1. Antacids
12.16.2. Antibiotics
12.16.3. H2 Blockers
12.16.4. Proton Pump Inhibitors (PPIs)
12.16.5. Prokinetics
12.16.6. Psychological Therapies
12.16.7. Others
12.17. U.K. Dyspepsia Market Forecast, By Diagnosis
12.17.1. Blood Tests
12.17.2. Breath Tests
12.17.3. Stool Tests
12.17.4. Endoscopy
12.17.5. X-ray
12.17.6. CT scan
12.17.7. Others
12.18. France Dyspepsia Market Forecast, By End-User
12.18.1. Hospitals and clinics
12.18.2. Ambulatory surgical centers
12.18.3. Pharmacies
12.18.4. Diagnostic centers
12.18.5. Others
12.19. France Dyspepsia Market Forecast, By Treatment
12.19.1. Antacids
12.19.2. Antibiotics
12.19.3. H2 Blockers
12.19.4. Proton Pump Inhibitors (PPIs)
12.19.5. Prokinetics
12.19.6. Psychological Therapies
12.19.7. Others
12.20. France Dyspepsia Market Forecast, By Diagnosis
12.20.1. Blood Tests
12.20.2. Breath Tests
12.20.3. Stool Tests
12.20.4. Endoscopy
12.20.5. X-ray
12.20.6. CT scan
12.20.7. Others
12.21. Italy Dyspepsia Market Forecast, By End-User
12.21.1. Hospitals and clinics
12.21.2. Ambulatory surgical centers
12.21.3. Pharmacies
12.21.4. Diagnostic centers
12.21.5. Others
12.22. Italy Dyspepsia Market Forecast, By Treatment
12.22.1. Antacids
12.22.2. Antibiotics
12.22.3. H2 Blockers
12.22.4. Proton Pump Inhibitors (PPIs)
12.22.5. Prokinetics
12.22.6. Psychological Therapies
12.22.7. Others
12.23. Italy Dyspepsia Market Forecast, By Diagnosis
12.23.1. Blood Tests
12.23.2. Breath Tests
12.23.3. Stool Tests
12.23.4. Endoscopy
12.23.5. X-ray
12.23.6. CT scan
12.23.7. Others
12.24. Spain Dyspepsia Market Forecast, By End-User
12.24.1. Hospitals and clinics
12.24.2. Ambulatory surgical centers
12.24.3. Pharmacies
12.24.4. Diagnostic centers
12.24.5. Others
12.25. Spain Dyspepsia Market Forecast, By Treatment
12.25.1. Antacids
12.25.2. Antibiotics
12.25.3. H2 Blockers
12.25.4. Proton Pump Inhibitors (PPIs)
12.25.5. Prokinetics
12.25.6. Psychological Therapies
12.25.7. Others
12.26. Spain Dyspepsia Market Forecast, By Diagnosis
12.26.1. Blood Tests
12.26.2. Breath Tests
12.26.3. Stool Tests
12.26.4. Endoscopy
12.26.5. X-ray
12.26.6. CT scan
12.26.7. Others
12.27. Rest of Europe Dyspepsia Market Forecast, By End-User
12.27.1. Hospitals and clinics
12.27.2. Ambulatory surgical centers
12.27.3. Pharmacies
12.27.4. Diagnostic centers
12.27.5. Others
12.28. Rest of Europe Dyspepsia Market Forecast, By Treatment
12.28.1. Antacids
12.28.2. Antibiotics
12.28.3. H2 Blockers
12.28.4. Proton Pump Inhibitors (PPIs)
12.28.5. Prokinetics
12.28.6. Psychological Therapies
12.28.7. Others
12.29. Rest Of Europe Dyspepsia Market Forecast, By Diagnosis
12.29.1. Blood Tests
12.29.2. Breath Tests
12.29.3. Stool Tests
12.29.4. Endoscopy
12.29.5. X-ray
12.29.6. CT scan
12.29.7. Others
12.30. Europe Dyspepsia Market Attractiveness Analysis
12.30.1. By End-User
12.30.2. By Treatment
12.30.3. By Diagnosis
12.31. PEST Analysis
12.32. Key Trends
12.33. Key Developments

13. Asia Pacific Dyspepsia Market Analysis
13.1. Key Findings
13.2. Asia Pacific Dyspepsia Market Overview
13.3. Asia Pacific Dyspepsia Market Value Share Analysis, By End-User
13.4. Asia Pacific Dyspepsia Market Forecast, By End-User
13.4.1. Hospitals and clinics
13.4.2. Ambulatory surgical centers
13.4.3. Pharmacies
13.4.4. Diagnostic centers
13.4.5. Others
13.5. Asia Pacific Dyspepsia Market Value Share Analysis, By Treatment
13.6. Asia Pacific Dyspepsia Market Forecast, By Treatment
13.6.1. Antacids
13.6.2. Antibiotics
13.6.3. H2 Blockers
13.6.4. Proton Pump Inhibitors (PPIs)
13.6.5. Prokinetics
13.6.6. Psychological Therapies
13.6.7. Others
13.7. Asia Pacific Dyspepsia Market Value Share Analysis, By Diagnosis
13.8. Asia Pacific Dyspepsia Market Forecast, By Diagnosis
13.8.1. Blood Tests
13.8.2. Breath Tests
13.8.3. Stool Tests
13.8.4. Endoscopy
13.8.5. X-ray
13.8.6. CT scan
13.8.7. Others
13.9. Asia Pacific Dyspepsia Market Value Share Analysis, by Country
13.10. Asia Pacific Dyspepsia Market Forecast, by Country
13.10.1. China
13.10.2. India
13.10.3. Japan
13.10.4. ASEAN
13.10.5. Rest of Asia Pacific
13.11. Asia Pacific Dyspepsia Market Analysis, by Country
13.12. China Dyspepsia Market Forecast, By End-User
13.12.1. Hospitals and clinics
13.12.2. Ambulatory surgical centers
13.12.3. Pharmacies
13.12.4. Diagnostic centers
13.12.5. Others
13.13. China Dyspepsia Market Forecast, By Treatment
13.13.1. Antacids
13.13.2. Antibiotics
13.13.3. H2 Blockers
13.13.4. Proton Pump Inhibitors (PPIs)
13.13.5. Prokinetics
13.13.6. Psychological Therapies
13.13.7. Others
13.14. China Dyspepsia Market Forecast, By Diagnosis
13.14.1. Blood Tests
13.14.2. Breath Tests
13.14.3. Stool Tests
13.14.4. Endoscopy
13.14.5. X-ray
13.14.6. CT scan
13.14.7. Others
13.15. India Dyspepsia Market Forecast, By End-User
13.15.1. Hospitals and clinics
13.15.2. Ambulatory surgical centers
13.15.3. Pharmacies
13.15.4. Diagnostic centers
13.15.5. Others
13.16. India Dyspepsia Market Forecast, By Treatment
13.16.1. Antacids
13.16.2. Antibiotics
13.16.3. H2 Blockers
13.16.4. Proton Pump Inhibitors (PPIs)
13.16.5. Prokinetics
13.16.6. Psychological Therapies
13.16.7. Others
13.17. India Dyspepsia Market Forecast, By Diagnosis
13.17.1. Blood Tests
13.17.2. Breath Tests
13.17.3. Stool Tests
13.17.4. Endoscopy
13.17.5. X-ray
13.17.6. CT scan
13.17.7. Others
13.18. Japan Dyspepsia Market Forecast, By End-User
13.18.1. Hospitals and clinics
13.18.2. Ambulatory surgical centers
13.18.3. Pharmacies
13.18.4. Diagnostic centers
13.19. Others Japan Dyspepsia Market Forecast, By Treatment
13.19.1. Antacids
13.19.2. Antibiotics
13.19.3. H2 Blockers
13.19.4. Proton Pump Inhibitors (PPIs)
13.19.5. Prokinetics
13.19.6. Psychological Therapies
13.19.7. Others
13.20. Japan Dyspepsia Market Forecast, By Diagnosis
13.20.1. Blood Tests
13.20.2. Breath Tests
13.20.3. Stool Tests
13.20.4. Endoscopy
13.20.5. X-ray
13.20.6. CT scan
13.20.7. Others
13.21. ASEAN Dyspepsia Market Forecast, By End-User
13.21.1. Hospitals and clinics
13.21.2. Ambulatory surgical centers
13.21.3. Pharmacies
13.21.4. Diagnostic centers
13.21.5. Others
13.22. ASEAN Dyspepsia Market Forecast, By Treatment
13.22.1. Antacids
13.22.2. Antibiotics
13.22.3. H2 Blockers
13.22.4. Proton Pump Inhibitors (PPIs)
13.22.5. Prokinetics
13.22.6. Psychological Therapies
13.22.7. Others
13.23. ASEAN Dyspepsia Market Forecast, By Diagnosis
13.23.1. Blood Tests
13.23.2. Breath Tests
13.23.3. Stool Tests
13.23.4. Endoscopy
13.23.5. X-ray
13.23.6. CT scan
13.23.7. Others
13.24. Rest of Asia Pacific Dyspepsia Market Forecast, By End-User
13.24.1. Hospitals and clinics
13.24.2. Ambulatory surgical centers
13.24.3. Pharmacies
13.24.4. Diagnostic centers
13.24.5. Others
13.25. Others Rest of Asia Pacific Dyspepsia Market Forecast, By Treatment
13.25.1. Antacids
13.25.2. Antibiotics
13.25.3. H2 Blockers
13.25.4. Proton Pump Inhibitors (PPIs)
13.25.5. Prokinetics
13.25.6. Psychological Therapies
13.25.7. Others
13.26. Rest of Asia Pacific Dyspepsia Market Forecast, By Diagnosis
13.26.1. Blood Tests
13.26.2. Breath Tests
13.26.3. Stool Tests
13.26.4. Endoscopy
13.26.5. X-ray
13.26.6. CT scan
13.26.7. Others
13.27. Asia Pacific Dyspepsia Market Attractiveness Analysis
13.27.1. By End-User
13.27.2. By Treatment
13.27.3. By Diagnosis
13.28. PEST Analysis
13.29. Key Trends
13.30. Key Developments

14. Middle East & Africa Dyspepsia Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Dyspepsia Market Overview
14.3. Middle East & Africa Dyspepsia Market Value Share Analysis, By End-User
14.4. Middle East & Africa Dyspepsia Market Forecast, By End-User
14.4.1. Hospitals and clinics
14.4.2. Ambulatory surgical centers
14.4.3. Pharmacies
14.4.4. Diagnostic centers
14.4.5. Others
14.5. Middle East & Africa Dyspepsia Market Value Share Analysis, By Treatment
14.6. Middle East & Africa Dyspepsia Market Forecast, By Treatment
14.6.1. Antacids
14.6.2. Antibiotics
14.6.3. H2 Blockers
14.6.4. Proton Pump Inhibitors (PPIs)
14.6.5. Prokinetics
14.6.6. Psychological Therapies
14.6.7. Others
14.7. Middle East & Africa Dyspepsia Market Value Share Analysis, By Diagnosis
14.8. Middle East & Africa Dyspepsia Market Forecast, By Diagnosis
14.8.1. Blood Tests
14.8.2. Breath Tests
14.8.3. Stool Tests
14.8.4. Endoscopy
14.8.5. X-ray
14.8.6. CT scan
14.8.7. Others
14.9. Middle East & Africa Dyspepsia Market Value Share Analysis, by Country
14.10. Middle East & Africa Dyspepsia Market Forecast, by Country
14.10.1. GCC
14.10.2. South Africa
14.10.3. Rest of Middle East & Africa
14.11. Middle East & Africa Dyspepsia Market Analysis, by Country
14.12. GCC Dyspepsia Market Forecast, By End-User
14.12.1. Hospitals and clinics
14.12.2. Ambulatory surgical centers
14.12.3. Pharmacies
14.12.4. Diagnostic centers
14.12.5. Others
14.13. GCC Dyspepsia Market Forecast, By Treatment
14.13.1. Antacids
14.13.2. Antibiotics
14.13.3. H2 Blockers
14.13.4. Proton Pump Inhibitors (PPIs)
14.13.5. Prokinetics
14.13.6. Psychological Therapies
14.13.7. Others
14.14. GCC Dyspepsia Market Forecast, By Diagnosis
14.14.1. Blood Tests
14.14.2. Breath Tests
14.14.3. Stool Tests
14.14.4. Endoscopy
14.14.5. X-ray
14.14.6. CT scan
14.14.7. Others
14.15. South Africa Dyspepsia Market Forecast, By End-User
14.15.1. Hospitals and clinics
14.15.2. Ambulatory surgical centers
14.15.3. Pharmacies
14.15.4. Diagnostic centers
14.15.5. Others
14.16. South Africa Dyspepsia Market Forecast, By Treatment
14.16.1. Antacids
14.16.2. Antibiotics
14.16.3. H2 Blockers
14.16.4. Proton Pump Inhibitors (PPIs)
14.16.5. Prokinetics
14.16.6. Psychological Therapies
14.16.7. Others
14.17. South Africa Dyspepsia Market Forecast, By Diagnosis
14.17.1. Blood Tests
14.17.2. Breath Tests
14.17.3. Stool Tests
14.17.4. Endoscopy
14.17.5. X-ray
14.17.6. CT scan
14.17.7. Others
14.18. Rest of Middle East & Africa Dyspepsia Market Forecast, By End-User
14.18.1. Hospitals and clinics
14.18.2. Ambulatory surgical centers
14.18.3. Pharmacies
14.18.4. Diagnostic centers
14.18.5. Others
14.19. Rest of Middle East & Africa Dyspepsia Market Forecast, By Treatment
14.19.1. Antacids
14.19.2. Antibiotics
14.19.3. H2 Blockers
14.19.4. Proton Pump Inhibitors (PPIs)
14.19.5. Prokinetics
14.19.6. Psychological Therapies
14.19.7. Others
14.20. Middle East & Africa Dyspepsia Market Forecast, By Diagnosis
14.20.1. Blood Tests
14.20.2. Breath Tests
14.20.3. Stool Tests
14.20.4. Endoscopy
14.20.5. X-ray
14.20.6. CT scan
14.20.7. Others
14.21. Middle East & Africa Dyspepsia Market Attractiveness Analysis
14.21.1. By End-User
14.21.2. By Treatment
14.21.3. By Diagnosis
14.22. PEST Analysis
14.23. Key Trends
14.24. Key Developments

15. South America Dyspepsia Market Analysis
15.1. Key Findings
15.2. South America Dyspepsia Market Overview
15.3. South America Dyspepsia Market Value Share Analysis, By End-User
15.4. South America Dyspepsia Market Forecast, By End-User
15.4.1. Hospitals and clinics
15.4.2. Ambulatory surgical centers
15.4.3. Pharmacies
15.4.4. Diagnostic centers
15.4.5. Others
15.5. South America Dyspepsia Market Value Share Analysis, By Treatment
15.6. South America Dyspepsia Market Forecast, By Treatment
15.6.1. Antacids
15.6.2. Antibiotics
15.6.3. H2 Blockers
15.6.4. Proton Pump Inhibitors (PPIs)
15.6.5. Prokinetics
15.6.6. Psychological Therapies
15.6.7. Others
15.7. South America Dyspepsia Market Value Share Analysis, By Diagnosis
15.8. South America Dyspepsia Market Forecast, By Diagnosis
15.8.1. Blood Tests
15.8.2. Breath Tests
15.8.3. Stool Tests
15.8.4. Endoscopy
15.8.5. X-ray
15.8.6. CT scan
15.8.7. Others
15.9. South America Dyspepsia Market Value Share Analysis, by Country
15.10. South America Dyspepsia Market Forecast, by Country
15.10.1. Brazil
15.10.2. Mexico
15.10.3. Rest of South America
15.11. South America Dyspepsia Market Analysis, by Country
15.12. Brazil Dyspepsia Market Forecast, By End-User
15.12.1. Hospitals and clinics
15.12.2. Ambulatory surgical centers
15.12.3. Pharmacies
15.12.4. Diagnostic centers
15.12.5. Others
15.13. Brazil Dyspepsia Market Forecast, By Treatment
15.13.1. Antacids
15.13.2. Antibiotics
15.13.3. H2 Blockers
15.13.4. Proton Pump Inhibitors (PPIs)
15.13.5. Prokinetics
15.13.6. Psychological Therapies
15.13.7. Others
15.14. Brazil Dyspepsia Market Forecast, By Diagnosis
15.14.1. Blood Tests
15.14.2. Breath Tests
15.14.3. Stool Tests
15.14.4. Endoscopy
15.14.5. X-ray
15.14.6. CT scan
15.14.7. Others
15.15. Mexico Dyspepsia Market Forecast, By End-User
15.15.1. Hospitals and clinics
15.15.2. Ambulatory surgical centers
15.15.3. Pharmacies
15.15.4. Diagnostic centers
15.15.5. Others
15.16. Mexico Dyspepsia Market Forecast, By Treatment
15.16.1. Antacids
15.16.2. Antibiotics
15.16.3. H2 Blockers
15.16.4. Proton Pump Inhibitors (PPIs)
15.16.5. Prokinetics
15.16.6. Psychological Therapies
15.16.7. Others
15.17. Mexico Dyspepsia Market Forecast, By Diagnosis
15.17.1. Blood Tests
15.17.2. Breath Tests
15.17.3. Stool Tests
15.17.4. Endoscopy
15.17.5. X-ray
15.17.6. CT scan
15.17.7. Others
15.18. Rest of South America Dyspepsia Market Forecast, By End-User
15.18.1. Hospitals and clinics
15.18.2. Ambulatory surgical centers
15.18.3. Pharmacies
15.18.4. Diagnostic centers
15.18.5. Others
15.19. Rest of South America Dyspepsia Market Forecast, By Treatment
15.19.1. Antacids
15.19.2. Antibiotics
15.19.3. H2 Blockers
15.19.4. Proton Pump Inhibitors (PPIs)
15.19.5. Prokinetics
15.19.6. Psychological Therapies
15.19.7. Others
15.20. Rest of South America Dyspepsia Market Forecast, By Diagnosis
15.20.1. Blood Tests
15.20.2. Breath Tests
15.20.3. Stool Tests
15.20.4. Endoscopy
15.20.5. X-ray
15.20.6. CT scan
15.20.7. Others
15.21. South America Dyspepsia Market Attractiveness Analysis
15.21.1. By End-User
15.21.2. By Treatment
15.21.3. By Diagnosis
15.22. PEST Analysis
15.23. Key Trends
15.24. Key Developments

16. Company Profiles
16.1. Market Share Analysis, by Company
16.2. Competition Matrix
16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
16.2.2. New Product Launches and Product Enhancements
16.2.3. Market Consolidation
16.2.3.1. M&A by Regions, Investment and Applications
16.2.3.2. M&A Key Players, Forward Integration and Backward Integration
16.3. Company Profiles: Key Players
16.3.1. AstraZeneca
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategy
16.3.1.5. Recent Developments
16.3.1.6. Development Footprint
16.3.2. GlaxoSmithKline
16.3.3. Takeda Pharmaceutical Company
16.3.4. Johnson & Johnson
16.3.5. Jiangsu Aosaikang Pharma
16.3.6. Eisai Co., Ltd.
16.3.7. Abbott Laboratories
16.3.8. Salix Pharmaceuticals
16.3.9. Bayer AG
16.3.10. Boehringer Ingelheim GmbH
16.3.11. Sanofi
16.3.12. Allergan Plc
16.3.13. Cadila Pharmaceuticals
16.3.14. Pfizer
16.3.15. Biogen
16.3.16. Astellas Pharma Inc.
16.3.17. ZERIA Pharmaceutical Co., Ltd
16.3.18. DONG - A ST
16.3.19. Beactica AB
16.3.20. Xian Janssen Pharmaceutical Ltd
16.3.21. Novartis AG
16.3.22. YUHAN
16.3.23. Abide Therapeutics, Inc.
17. Primary Key Insights
  • INQUIRE BEFORE BUYING